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Abstract: The marine environment is potentially a prolific source of small molecules with significant
biological activities. In recent years, the development of new chromatographic phases and the
progress in cell and molecular techniques have facilitated the search for marine natural products
(MNPs) as novel pharmacophores and enhanced the success rate in the selection of new potential
drug candidates. However, most of this exploration has so far been driven by anticancer research
and has been limited to a reduced number of taxonomic groups. In this article, we report a test
study on the screening potential of an in-house library of natural small molecules composed of
285 samples derived from 57 marine organisms that were chosen from among the major eukaryotic
phyla so far represented in studies on bioactive MNPs. Both the extracts and SPE fractions of these
organisms were simultaneously submitted to three different bioassays—two phenotypic and one
enzymatic—for cytotoxic, antidiabetic, and antibacterial activity. On the whole, the screening of
the MNP library selected 11 potential hits, but the distribution of the biological results showed that
SPE fractionation increased the positive score regardless of the taxonomic group. In many cases,
activity could be detected only in the enriched fractions after the elimination of the bulky effect due
to salts. On a statistical basis, sponges and molluscs were confirmed to be the most significant source
of cytotoxic and antimicrobial products, but other phyla were found to be effective with the other
therapeutic targets.
Keywords: marine natural products; small molecules; drug discovery platform; pre-fractionation
method; active metabolites; cytotoxic; antimicrobial and antidiabetic activity
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1. Introduction
Natural products and their derivatives have long been an inspiration in drug discov-
ery. Among these, marine natural products (MNPs) are generally characterized by high
chemical diversity and unusual pharmacological properties that make them suitable as
lead structures in the development of new drugs. A significant number of pharmacological
activities from MNPs have so far been reported in various fields, including analgesic,
anti-inflammatory, antibiotic, antibacterial, antifungal, antiviral, and antiparasitic [1]. In
recent years, the techniques used to identify and characterize the new products have been
improved and a large number of new databases have been implemented, with the aim of
classifying and simplifying their selection [2]. In addition, increasingly more advanced
tests have been developed in order to improve both the accuracy of preclinical selection and
the clinical prediction required for subsequent translational developments [3]. As a result
of these efforts, a growing number of compounds from marine sources are in clinical trials,
and there is a general consensus on the increasing impact of MNPs on the pharmaceutical
industry in the coming years [4,5]. However, there are still several challenges associated
with the experimental approaches in marine drug discovery, including supply limitation,
structural complexity, rediscovery rates, moderate structure stability, and the masking of
bioactive compounds. In particular, as preliminary screenings are carried out by using
crude or semi-fractionated mixtures, a large amount of inorganic salts and neutral lipids
can interfere with the biological response and can hide the presence of the active products.
To bypass these problems, different fractionation methods have been developed to treat
the extract before the biological assays [6,7].
In our laboratory, we set up and validated a Solid Phase Extraction (SPE) procedure
based on a hydrophobic resin [8]. Compared to crude extracts, SPE samples, although
still made up of complex mixtures, showed an improved screening performance (with
a higher confidence in observed hit rates), enhanced biological activity due to the major
concentration of active components present as only minor metabolites, as well as simplified
processes for the dereplication and isolation of the bioactive molecules. In the present
study, we aimed to test this approach in a totally automatized screening platform by using,
as proof of concept, an in-house library of small molecules composed of the extracts from
57 marine macro- and micro-organisms chosen from among the major eukaryotic phyla so
far considered for bioprospection. The samples were screened for antitumor, antibiotic, and
antidiabetic activity by two complementary approaches based on a phenotypic (classical
pharmacology) and a target-based assay (reverse pharmacology) [9]. The first approach
consisted of viability tests for cytotoxic activity and bacterial density measurement for
bactericide evaluation. The second approach was a type 2 diabetes enzymatic assay, used
for the identification of molecules that are able to inhibit Protein Tyrosine Phosphatase 1B
(PTP-1B), which arrests the signalling of the insulin receptor in vivo and is essential for the
physiological control of glycaemia increase in insulin-responsive tissues [10].
2. Results and Discussion
2.1. Collection of Organisms
Fifty-seven different marine organisms, selected from among benthic invertebrates
and microorganisms, were collected in order to obtain a biologically diversified source
of natural extracts (Figure 1). In addition to their availability, these specimens offered
a wide evolutionary heterogeneity that allowed for a good diversification of secondary
metabolites. The organism collection, based on their origin, can be classified into two main
groups: cultured microorganisms (in-house and outsourced) and collected species. This
latter group is formed by organisms coming from the Mediterranean Sea and Antarctica.
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carterae (Hulburt) were obtained from their algal hosts. Diatoms Thalassiosira rotula 
(Meunier) and Phaeodactylum tricornutum (Bohlin) were isolated from seawater samples, 
while Thalassiosira pseudonana (Hasle and Heimdal), Skeletonema marinoi (Sarno and Zin-
gone), and Cyclotella cryptica (Reimann, J.C.Lewin, and Guillard) were purchased from the 
Culture Collection of Marine Phytoplankton (CCMP). Four species of microalgae (Tre-
traselmis suecica, Tetraselmis sp., Nannochloropsis sp., and Isochrysis galbana) were obtained 
as lyophilized samples from external producers. The source of each microorganism and 
the assigned codes are reported in Table 1. Unless differently stated, these species were 
cultured up to the stationary phase and centrifuged according to our previously reported 
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Figure 1. Phyla distribution of marine organisms processed by the screening platform.
2.1.1. Cultured Microorganisms
In-house cultured organisms included protists from the phyla Bacillariophyta
(diatoms), Rhodophyta (red algae), Chlorophyta (green algae), Haptophyta, and Mio-
zoa (dinoflagellates). The dinoflagellates Heterocapsa sp. and Scrippsiella sp. were iso-
lated from seawater samples, while the epiphytes Amphidinium massartii (Biecheler) and
Amphidinium carterae (Hulburt) were obtained from their algal hosts. Diatoms Thalas-
siosira rotula (Meunier) and Phaeodactylum tricornutum (Bohlin) were isolated from seawater
samples, while Thalassiosira pseudonana (Hasle and Heimdal), Skeletonema marinoi (Sarno
and Zingone), and Cyclotella cryptica (Reimann, J.C.Lewin, and Guillard) were purchased
from the Culture Collection of Marine Phytoplankton (CCMP). Four species of microalgae
(Tretraselmis suecica, Tetraselmis sp., Nannochloropsis sp., and Isochrysis galbana) were obtained
as lyophilized samples from external producers. The source of each microorganism and
the assigned codes are reported in Table 1. Unless differently stated, these species were
cultured up to the stationary phase and centrifuged according to our previously reported
procedures [8]. The wet pellets were immediately frozen and stored until extraction.
Table 1. Cultured microorganisms used to prepare the MNP library.
Phylum Taxon Ident Code Origin
Bacillariophyta Cyclotella cryptica CB 25A CCMP331 (NCMA)
Bacillariophyta Thalassiosira pseudonana CBC36A CMP1335 (NCMA)
Bacillariophyta Skeletonema marinoi CBC40A CCMP2092 (NCMA)
Bacillariophyta Thalassiosira rotula CBC41A New isolate (Gulf of Naples, WesternMediterranean Sea)
Bacillariophyta Phaeodactylum tricornutum CBC42A New isolate (Gulf of Naples, WesternMediterranean Sea)
Chlorophyta Tetraselmis suecica CBC20A Neoalgae
Chlorophyta Tetraselmis sp. CBC27A Phytobloom
Hapt phyta Isochrysis galbana CBC21A Phytobloom
Oc r phyta Nannochloropsi . CBC24A Phytobloom
Miozoa Amphidinium massartii CBC39A New isolate (Gulf of Naples, WesternMediterranean Sea)
Miozoa Amphidinium carterae CBC35A New isolate (Fusaro lake, brakish lagoon)
Miozoa Heterocapsa sp. CBC53A New isolate (Gulf of Naples, WesternMediterranean Sea)
Miozoa Scrippsiella sp. CBC55A New isolate (Gulf of Naples, WesternMediterranean Sea)
2.1.2. Benthic Invertebrates and Algae
Invertebrates comprise the group richest in biodiversity among animals and include
about 30 phyla. The major phyla include Porifera, Cnidaria, Annelida, Bryozoa, Mollusca,
Arthropoda, and Echinodermata [11]. Some of these phyla are characterized by few species,
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while others include more than 85% of all described animal species and consist of over a
million species [11]. In 2012, Leal et al. [12] reported the characterized MNPs and classified
them according to phyla based on their invertebrate source. They found that approximately
80% of these were from the phyla Porifera (47.1%) and Cnidaria (32.9%).
As shown in Figure 1, poriferans, molluscs, and tunicates account for more than fifty
percent of the organisms that were selected in the present study. Such a distribution reflects
the number of studies that have so far been carried out on MNPs [13]. In particular, porifer-
ans are one of the main sources of bioactive MNPs, providing a good number of molecules
already available as drugs or candidates in clinical trials [14], along with algae, molluscs,
and corals as well as microorganisms, which have recently and significantly contributed to
the discovery of novel MNPs [14,15]. Eighteen of the forty-four organisms were collected in
the Antarctic Ocean (Ross Sea), whereas the remaining ones come from the Mediterranean
Sea, mostly collected in the Gulf of Naples (Italy). For most of them, the taxonomical iden-
tification was available (Table 2), while for the taxonomically undefined samples, voucher
specimens in ethanol are deposited at the CNR-Institute of Biomolecular Chemistry.
Table 2. Benthic organisms used to prepare the MNP library. The biological samples were collected in the Mediterranean
Sea and Antarctic Ocean.
Phylum Taxonomy/Voucher Code Identification Code Collection Site
Bryozoa Bugula neritina complex CBC28A Gulf of Naples, Western Mediterranean Sea
Bryozoa Amathia verticillata CBC30A Gulf of Naples, Western Mediterranean Sea
Bryozoa Schizoporella errata CBC31A Gulf of Naples, Western Mediterranean Sea
Bryozoa Lepraliellidae ind. CBC44A Gulf of Naples, Western Mediterranean Sea
Bryozoa ITA-AM 15 12/13 CBC48A Antarctica
Chlorophyta Codium bursa CBC33A Gulf of Naples, Western Mediterranean Sea
Chordata (Tunicata) Ciona robusta CBC18A Gulf of Naples, Western Mediterranean Sea
Chordata (Tunicata) Halocynthia papillosa CBC19A Gulf of Naples, Western Mediterranean Sea
Chordata (Tunicata) Styela plicata CBC22A Gulf of Naples, Western Mediterranean Sea
Chordata (Tunicata) Ascidiella aspersa CBC29A Off the coast of Crotone, Ionian Sea
Chordata (Tunicata) Botryllus schlosseri complex CBC37A Gulf of Naples, Western Mediterranean Sea
Chordata (Tunicata) ITA-AM 12 12/13 CBC50A Antarctica
Cnidaria Leptogorgia sarmentosa CBC23A Gulf of Naples, Western Mediterranean Sea
Cnidaria ITA-AM 13 12/13 CBC51A Antarctica
Cnidaria ITA-AM 14 12/13 CBC62A Antarctica
Mollusca Philine quadripartita CBC26A Off the coast of Crotone, Ionian Sea
Mollusca Hexaplex trunculus complex CBC34A Gulf of Naples, Western Mediterranean Sea
Mollusca Euthria cornea CBC38A Gulf of Naples, Western Mediterranean Sea
Mollusca Gasteropteron rubrum CBC46C Off the coast of Crotone, Ionian Sea
Mollusca Gasteropteron rubrum CBC46A Western Mediterranean Sea
Mollusca Scaphander lignarius complex CBC47A Off the coast of Crotone, Ionian Sea
Ochrophyta Cystoseira dubia CBC49A Off the coast of Crotone, Ionian Sea
Ochrophyta Dictyota sp. CBC45A Gulf of Naples, Western Mediterranean Sea
Porifera Haliclona mediterranea CBC1A Gulf of Naples, Western Mediterranean Sea
Porifera Chondrosia reniformis CBC2A Gulf of Naples, Western Mediterranean Sea
Porifera Crambe crambe CBC3A Gulf of Naples, Western Mediterranean Sea
Porifera Chondrilla nucula CBC4A Gulf of Naples, Western Mediterranean Sea
Porifera ITA-AM 09 12/13 CBC10A Antarctica
Porifera Spongia sp. (ITA-AM 06 16) CBC12A Off the coast of Crotone, Ionian Sea
Porifera ITA-AM 07 02 CBC11A Antarctica
Porifera ITA-AM 08 02 CBC15A Antarctica
Porifera ITA-AM 02 02 CBC13A Antarctica
Porifera ITA-AM 04 02 CBC14A Antarctica
Porifera ITA-AM 05 02 CBC16A Antarctica
Porifera ITA-AM 03 02 CBC17A Antarctica
Porifera Spirastrella cunctatrix CBC32A Gulf of Naples, Western Mediterranean Sea
Porifera ITA-AM 10 12/13 CBC56A Antarctica
Porifera ITA-AM 11 12/13 CBC57A Antarctica
Porifera Dendrilla sp. (GAN-38) CBC74A-1 Antarctica
Porifera Dendrilla sp. (GAN-54) CBC74B Antarctica
Porifera Dendrilla sp. (GAN-53) CBC74A-3 Antarctica
Porifera GAN-3 CBC75A Antarctica
Porifera GAN-37 CBC77A Antarctica
Rhodophyta Pterocladiella capillacea CBC43A Gulf of Naples, Western Mediterranean Sea
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2.2. Library of Marine Natural Products Extracts
Raw extracts were obtained by an exhaustive extraction of each marine organism with
MeOH. After the evaporation of the solvent by rotavapor, the samples were transferred
using a mixture of MeOH/Dichloromethane (DCM) 2:1 (v/v) to partially desalt the extracts
by salt precipitation. After the removal of the solvent under nitrogen, the dry extracts were
stored under argon at −80 ◦C until use.
In agreement with [8], SPE fractionation was based on the use of the hydrophobic solid
phase of polystyrene–divinylbenzene. Each marine extract (50 mg for benthic species and
25 mg for microalgae) was loaded as a water suspension, and fractionation was achieved
by a stepwise solvent gradient elution. Briefly, the first mobile phase used pure water
(fraction A) for an efficient desalting. Organic compounds were then eluted in the four
next fractions with MeOH:H2O 1:1 (v/v), Acetonitrile (ACN):H2O 7:3 (v/v), ACN, and
DCM:MeOH 9:1 (v/v) (fractions B–E). This procedure gave a reproducible and accurate
fractionation of the organic chemical classes, from polar to apolar products. The percentage
of each fraction in the whole extract for phylum is reported in Table 3. The distribution
of the metabolites in the enriched fractions for each SPE was monitored by thin layer
chromatography (TLC) and 1H NMR. Overall, the pre-fractionation platform generated an
MNP library composed of 228 enriched fractions and 57 raw extracts to be tested.
Table 3. Percentage contribution of each SPE fraction to the total loaded extract considered for the taxonomic groups
represented in the library. Recovery of total organic compounds (OCs) was calculated as the sum of the SPE fractions B–E.
Phylum Frac. A % Frac. B % Frac. C % Frac. D % Frac. E% Total OCs %
Bacillariophyta 39.8 ± 9.3 11.7 ± 6.4 11.4 ± 3 10.4 ± 4.2 15.2 ± 10.4 48.7
Bryozoa 71.3 ± 8.2 3.2 ± 2.0 3.6 ± 1.2 2.1 ± 0.7 5.3 ± 2.0 14.2
Chlorophyta 52.6 ± 18.8 5.0 ± 6.1 8.0 ± 6.7 5.8 ± 4.3 6.6 ± 5.0 25.4
Chordata (Tunicata) 72.3 ± 9.7 2.6 ± 0.8 3.3 ± 1.7 3.1 ± 1.8 3.9 ± 1.8 12.9
Cnidaria 44.1 ± 12.9 3.6 ± 1.0 4.1 ± 1.4 5.8 ± 1.5 7.0 ± 3.6 20.6
Haptophyta 49.4 8.4 0.9 16.9 7.8 34.0
Miozoa 44.7 ± 8.1 3.9 ± 2.3 6.8 ± 4.1 8.4 ± 4.5 9.0 ± 5.1 28.0
Mollusca 63.7 ± 7.2 3.9 ± 0.9 3.9 ±1.4 2.9 ± 1.3 5.8 ± 2.4 16.5
Ochrophyta 56.1 ± 10.6 1.8 ± 2.4 4.1 ± 3.6 4.2 ± 4.7 6.2 ± 6.3 16.4
Porifera 62.0 ± 17.4 4.7 ± 2.1 3.7 ± 2.4 3.8 ± 2.7 5.8 ± 3.0 18.1
Rhodophyta 71.0 1.1 2.9 0.7 1.2 5.9
2.3. Bioassays
For the biological screening, three different bioassays were implemented, including
both cell-based assays and a biochemical assay. The test panel relied on the three different
screening platforms, fast to perform with very low amount of material: two phenotypic
assays, to test cytotoxicity and antimicrobial activity, and one targeted to evaluate antidia-
betic activity.
2.3.1. Cytotoxic and Antimicrobial Bioassays
The extracts and fractions were tested on two human cancer cell lines, A549 (adenocar-
cinoma human alveolar basal epithelial cells) and A2780 (human ovarian cancer cell line),
together with PNT2 (normal prostate epithelium immortalized with SV40), which was
used as control. The choice of these cell lines was associated with the frequency of these
tumors, their metastatic potential, their easy manipulation, and their high proliferation rate
compared with other available cell lines.
Cytotoxicity was measured after 48 h of incubation with the MTT assay [16] (File S1
of the Supporting Material). The results were expressed as the percentage of cell vitality
after treatment at three different concentrations (1, 10, and 100 µg/mL) with extracts
and fractions; values were calculated as the ratio between the mean absorbance of each
treatment and the mean absorbance of control (untreated cells). The effect on the survival of
control cells at multiple extract concentrations allowed for the prioritization of hit extracts
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before further studies. Samples resulting as cytotoxic only at the highest concentration
(100 µg/mL) were considered not of interest. A statistical analysis of phyla with a non-
parametric Kruskal–Wallis test revealed that the most significant results were observed at
10 µg/mL (Figure S1). At this concentration, treatment with Haptophyta, Bryozoa, Miozoa,
Mollusca, and Ochorophyta showed a significant difference versus control (p-value < 0.05)
in all the cell lines (Figure 2), although for Bryozoa and Miozoa, these differences were
ascribable to the increase of cell proliferation instead of cytotoxicity. Considering only the
effects related to toxicity, Cnidaria and Porifera induced a significant reduction of growth
on A549 and PTN2, as well as Chlorophyta on A2789 and PTN2.





Figure 2. Distribution of positive hits among the taxonomic groups represented in the library. (a) Kruskal–Wallis test (non-
parametric test) performed for each cell line (A2780, A549, PNT2) at a dose of 10 μg/mL. Post hoc tests were applied to 
identify which phylum groups were statistically different (significant codes: 0.0001 ‘****’, 0.01 ‘**’, 0.05 ‘*’). (b) Positive 
(negative) log2 fold-change for significant comparisons (i.e., p-value < 0.05) between phylum groups and untreated cells 
(CTRL-) are shown. Red line indicates treatment with 50% mortality. 
Exclusively considering samples that were able to reduce cell vitality to below 80% 
at 1 or 10 μg/mL in the A549 and A2780 lines, we compared the number of organisms 
active as raw extracts with organisms active only after fractionation. Results showed an 
increase in positive hits by more than 35% after SPE fractions (Figure 3). Analysis of these 
data underlined that Bacillariophyta, Mollusca, and Chordata (Tunicata) were the phyla 
whose activity took most advantage of the fractionation and showed the highest increase 
in positive hits in comparison to raw extracts. Only in one case, namely, the bryozoan 
Amathia verticillata CBC30A, was the activity detected solely in the extract. Parallel tests 
on the three cell lines allowed for the identification of samples that differentially affected 
the two cancer models, as well as the detection of non-specific cytotoxic compounds and 
false positives (data not shown). 
Figure 2. Distribution of positive hits among the taxonomic groups represented in the library. (a) Kruskal–Wallis test
(non-parametric test) performed for each cell line (A2780, A549, PNT2) at a dose of 10 µg/mL. Post hoc tests were applied
to identify which phylum groups were statistically different (significant codes: 0.0001 ‘****’, 0.01 ‘**’, 0.05 ‘*’). (b) Positive
(negative) log2 fold-change for significant comparisons (i.e., p-value < 0.05) between phylum groups and untreated cells
(CTRL-) are shown. Red line indicates treatment with 50% mortality.
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Exclusively considering samples that were able to reduce cell vitality to below 80%
at 1 or 10 µg/mL in the A549 and A2780 lines, we compared the number of organisms
active as raw extracts with organisms active only after fractionation. Results showed an
increase in positive hits by more than 35% after SPE fractions (Figure 3). Analysis of these
data underlined that Bacillariophyta, Mollusca, and Chordata (Tunicata) were the phyla
whose activity took most advantage of the fractionation and showed the highest increase
in positive hits in comparison to raw extracts. Only in one case, namely, the bryozoan
Amathia verticillata CBC30A, was the activity detected solely in the extract. Parallel tests on
the three cell lines allowed for the identification of samples that differentially affected the
two cancer models, as well as the detection of non-specific cytotoxic compounds and false
positives (data not shown).
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Figure 3. Cytotoxic activity of the taxonomic groups represented in the library. (a) Total percentages of positive hits against 
cancer cell lines A549 and A2780. (b) Number of cytotoxic species grouped by phyla. Blue indicates organisms with activity 
in raw extracts and SPE fractions. White indicates organisms with activity only in SPE fractions. Grey indicates samples 
that are not active. 
Figure 4 summarizes the activity on the three cell lines after treatment with the raw 
extracts (X) and related SPE fractions (B, C, D, E) at 10 μg/mL. Among the protist phyla, 
the two dinoflagellates, Heterocapsa sp. (CBC53A) and Scrippsiella sp. (CBC55A), were cy-
totoxic, with an enrichment of the activity after fractionation and a mild effect on the non-
tumorigenic cell line PNT2. Moreover, fraction E of the diatom Tetraselmis sp. (CBC20A) 
displayed a specific cytotoxicity on the A2780 cell line, showing a strong inhibition of cell 
proliferation (29.8% of cell viability) at 1 μg/mL (Figure S3). Similar results were obtained 
with fraction C of Amphidinium carterae (CBC35A), which affected A2780 cell viability 
(37.8%) at 1 μg/mL of the tested concentration (Figure S3). 
On the whole, in line with the literature, the most active extracts were associated with 
the phylum Porifera (Figure 4). Sponge fractions showed little specificity since the most 
cytotoxic samples were indifferently active on both the two tumor cell lines and controls. 
These samples included species already known for the presence of toxic metabolites such 
as Spirastrella cunctatrix CBC32A [17,18], Crambe CBC03A [19], and the Antartic sponge 
Dendrilla sp. CBC74A [20,21]. 
Between the two cancer cell lines, pulmonary adenocarcinoma cells (A549) appeared 
to be more resistant to treatment with samples from molluscs, cnidarians, and bryozoans. 
Within molluscs, fraction D of Philina quadripartita (CBC26A) reduced viability to 66.2% at 
10 μg/mL, with a clear dose-dependent response effect. Analogously, fractions D and E of 
the cnidarian extract CBC51A and fractions C and D of Bugula neritina (CBC28A) reduced 
the cell survival of A549 by a percentage (around 65% at 10 μg/mL) strongly dependent 
on the concentration of the active component. 
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Figure 4 summarizes the activity on the three cell lines after treatment with the raw
extracts (X) and related SPE fractions (B, C, D, E) at 10 µg/mL. Among the protist phyla,
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proliferation (29.8 of cell viability) at 1 µg/ L (Figure S3). Si ilar results ere obtained
ith fraction of phidiniu carterae ( B 35 ), hich affected 2780 cell viability
(37.8 ) at 1 µg of the teste concentration (Fig re S3).
t e le, i li e it t e literat re, t e st acti e e tracts ere ass ciate it
t l rif r ( i r ). fr ti s s littl s ifi it si t st
t t i l i iff tl ti t t t t ll li t l .
f i t lit
, t t rti s
.
ll
it i ll scs, fr cti f ili i rtit ( ) ce i ilit t . t
µ , it cl r s - , ti s f
l i i
t ll i l f a percentage (around 65 at 10 µg/ ) t l e t
t tr ti f t ti t.
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2.3.2. nti icrobial Bioassay
The second biological investigation of our MNP library included tests for potential
anti icrobial activity. The large use of antibiotics and the concomitant development of
biological resistance have rendered the identification of novel antimicrobial compounds of
vital importance to the prevention of the spread of infections due to resistant bacteria [22].
For antibacterial screening, we selected a small panel of diverse pathogens, including
three Gram+ (Staphylococcus. Aureus; Enterococcus faecalis, and Streptococcus agalactiae) and
two Gram− (Escherichia coli and Pseudomonas aeruginosa) strains that have been routinely
used as quality controls in clinical laboratories (EUCAST E. Dis 5.1. March 2003). The
bacterial strains were grown in multi-well plates and treated with 50 µg/mL of either
extract or fractions B-E. The effects of this treatment were measured after 20 h, and the
results were expressed as percentage of growth control (untreated bacteria) (File S2 of
Supplementary Material).
In comparison to the cytotoxicity reported above, most of the samples (59%) did not
show any antimicrobial potential. However, the tests showed a clear increase in activity
after fractionation, with a positive response in 6% of the raw extracts versus 35% of positive
hits in the enriched SPE fractions (Figure 5). With the exception of dinoflagellates and
diatoms, microalgae did not seem to produce antimicrobial products. On the contrary, the
best positive score was observed in molluscs, with almost 80% of the samples showing
antimicrobial activity, and sponges.
As reported in Figure 6, most of the active samples exhibited activity only against
Gram+ strains. In general, Streptococcus agalactiae was much more sensitive than Staphy-
lococcus aureus and Enterococcus faecalis in the tests with the MNPs. Regardless of the
taxonomic groups, most of the activities were related to the SPE fractions C and D, which
are particularly enriched in small molecules with little polarity such as terpenes, sterols,
and polyketides. In agreement with the literature [23,24], the extract and the SPE fractions
B and C of the sponge Crambe crambe (CBC03A) were active against both Gram− and
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Gram+ strains. This sponge showed almost 100% inhibition of bacterial growth and was
also the only species with promising effectiveness in targeting Gram− pathogens.
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inhibition of the recombinant human PTP-1B protein together with the T Cell-PTP counter 
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fractions of the MNP library, and inhibition was calculated by comparing measurements 
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activity, and fractions that were active only against the PTP-1B were selected.  
Only four organisms, including the mollusc Gastropteron rubrum (CBC46C), the chor-
date CBC50A, the cnidarian CBC51A, and the dinoflagellate Scrippsiella sp. (CBC55A), 
showed noteworthy properties (Supporting Material, File S3). Significantly, PTP-1B activ-
ity was below 30% only in enriched samples after SPE fractionation (Figure 7), thus further 
confirming the potential of the pre-fractionation platform. Similar to the antimicrobial ac-
tivity, SPE fractions C and D were those containing the active compounds. Fractions of 
Gastropteron rubrum (CBC46C-C) and the cnidarian CBC51A (CBC51A-D) were specific 
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contrast to the cytotoxic and antimicrobial tests, sponges did not give positive hits. 
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Crambescedins are the main metabolites of C. Crambe [19]. These compounds are
good candidates for the antimicrobial activity of this sponge. Nevertheless, the iden-
tification of the single bioactive moelcule was aside the aim of the present study, and
further investigations are necessary to confirm the chemical agents responsible for the
observed activity.
2.3.3. Antidiabetic Bioassay
In addition to the two phenotypic assays, we tested the potential of our chemi-
cal library of MNPs to target protein tyrosine phosphatase 1B (PTP-1B), a key signal-
transduction regulator involved in the etiology of diabetes mellitus [25]. PTP-1B functions
as a negative regulator of insulin and as a drug target in order to ameliorate resistance to
the hormone [26]. For the screening of the MNP library, we used an enzymatic assay for the
inhibition of the recombinant human PTP-1B protein together with the T Cell-PTP counter
screen assay to check for enzymatic specificity [27]. We also tested 50 µg/mL extracts or
fractions of the MNP library, and inhibition was calculated by comparing measurements
with controls (no treatment). Activity threshold was set to less than 30% of the enzymatic
activity, and fractions that were active only against the PTP-1B were selected.
Only four organisms, including the mollusc Gastropteron rubrum (CBC46C), the chor-
date CBC50A, the cnidarian CBC51A, and the dinoflagellate Scrippsiella sp. (CBC55A),
showed noteworthy properties (Supporting Material, File S3). Significantly, PTP-1B activity
was below 30% only in enriched samples after SPE fractionation (Figure 7), thus further
confirming the potential of the pre-fractionation platform. Similar to the antimicrobial
activity, SPE fractions C and D were those containing the active compounds. Fractions
of Gastropteron rubrum (CBC46C-C) and the cnidarian CBC51A (CBC51A-D) were specific
for PTP-1B, thus resulting as the most promising candidates for further development. In
contrast to the cytotoxic and antimicrobial tests, sponges did not give positive hits.





Figure 7. Enzymatic tests for the selection of antidiabetic candidates. (a) PTP 1B inhibition by selected samples from the 
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inverse TCI CryoProbe or 400 equipped with a CryoProbe Prodigy. Extracts were dis-
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3. Materials and Methods
3.1. General
All the chemicals and solvents (Sigma-Aldrich, Milan, Italy) were of analytical reagent
grade and were used without any further purification. For the centrifugation of in-house
cultured organisms, we used an Allegra X-12R centrifuge (Beckman Coulter, Milan, Italy).
The solid phase extraction was carried out using both prepacked and non-polystyrene–
divinylbenzene columns (CHROMABOND® HR-X, Macherey-Nagel, Düren, Germany).
Automated fractionations were carried out on the GX-271 ASPEC Gilson apparatus
equipped with TRILUTION® LH Software (version No. 3.0, Gilson, Middleton, WI, USA).
Silica gel chromatography was performed using prec ated Merck F254 plates.
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1H NMR spectra were recorded on a Bruker DRX 600 spectrometer equipped with an
inverse TCI CryoProbe or 400 equipped with a CryoProbe Prodigy. Extracts were dissolved
in 700 µL CDCl3/CD3OD 1:1 (v/v) and transferred to the 5 mm NMR tube. Chemical shift
was referred to CHD2OD signal at δ 3.34.
3.2. Marine Organism Sources
3.2.1. Cultured Algae
Nine of our microalgae were cultured in-house (see Table 1), in 10 or 2 L polycarbonate
carboys, in a room with controlled temperature (20–22 ◦C) via sterile air injectors, and
artificial illumination using cool fluorescent tubes.
Miozoa were isolated directly from seawater by the capillary pipette method. The
free-living species Heterocapsa sp. and Scrippsiella sp. were directly picked up from seawater
samples, while the epiphytes Amphidinium massartii and Amphidinium carterae first required
detachment from the macroalgae Asparagopsis taxiformis (Delile) Trevisan and Dictyota
dichotoma (Hudson) J.V. Lamouroux samples, respectively. To do this, the host seaweeds
were vigorously shaken in plastic bags containing filtered seawater, which was then used
to apply the conventional procedure of single-cell isolation. All species were cultured
in K medium [28] using air bubbling (ca. 3 L/min) provided by filter venting devices.
Dinoflagellates were grown under an artificial light intensity of 100 µmol photons m−2 s−1
and a 14:10 light:dark photoperiod. The culture lasted for 12–15 days until the stationary
phase, which was then harvested by centrifugation (2300× g, 12 ◦C, 10 min per round) and
stored frozen until extraction.
Bacillariophyta (diatoms) were cultured in f/2 medium [29] at higher irradiances
(200 µmol photons m−2 s−1); other conditions were similar to those already mentioned.
Thalassiosira rotula and Phaeodactylum tricornutum were obtained directly from seawater
samples and isolated via the capillary pipette method. The remaining three diatoms,
Thalassiosira pseudonana, Skeletonema marinoi, and Cyclotella cryptica, were purchased from
the National Center for Marine Algae and Microbiotics (NCMA).
Tetraselmis suecica was bought as dry biomass from Neoalgae Microseaweeds Products,
Gijón, Spain, while Tetraselmis sp., Nannochloropsis sp., and Isochrysis galbana were purchased
from Phytobloom, Necton.
3.2.2. Benthonic Invertebrates and Algae Sampled
Benthic organisms were collected directly from the sea during various sampling
campaigns (see Table 2). They were frozen as soon as possible and stored at −20 ◦C until
they were processed.
3.3. Methanol Extraction of the Organisms
All the samples were weighted prior to proceeding with solvent extraction. Porifera
were lyophilized and then weighted as dry biomass.
Extraction proceeded by covering each organism with methanol and grounding it
with a mortar in such way that most of the volume was exposed to the solvent; it was
then extracted exhaustively using mechanical means and sonication. This procedure was
repeated at least two times, and the recovered solvent was mixed. During the extraction of
the samples, an ice bath was used to keep the temperature of the extract low and prevent
degradation. For the extractions of microalgal pellets, a volume of 5 mL of methanol per
gram of sample was used, combined with sonication to disrupt the cells.
The extracts were filtered with a rinsed filter paper, and dried in a rotatory evaporator
using a maximum temperature of 27 ◦C. This full crude extract was weighted and aliquoted
when transferred to vials, using methanol–dichloromethane 2:1 (v/v) as solvent. Finally,
this crude extract was dried under a nitrogen flow and kept dry at −80 ◦C.
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3.4. Solid Phase Extraction
An aliquot (about 50 mg, and 25 mg for more lipophilic samples) of raw extracts was
suspended in 1 mL of MilliQ water, using sonication as needed, and then incorporated into
the columns of the automatic SPE device.
The instrument was first programmed to activate the column by eluting with 5 mL
methanol, followed by equilibration with 10 mL of MilliQ water. The next step consisted in
loading the 1 mL extract suspension to the column. Then, another 2 mL of MilliQ water was
added to the extract vial to be pipetted in order to resuspend as much remaining extract as
possible. The leftover was then added to the column. Then, another 6 mL of MilliQ water
was added directly to the column to complete the elution of fraction A. Afterwards, 9 mL of
each eluent was used stepwise to obtain the corresponding fractions B (methanol-water 1:1),
C (acetonitrile-water 7:3), D (pure acetonitrile), and E (dichloromethane-methanol 9:1). The
eluted fractions were transferred to round bottom flasks and dried in a rotatory evaporator
using a maximum temperature of 27 ◦C. The content from the round bottom flasks was
then transferred to vials, dried under nitrogen flow, weighted, and conserved at −80 ◦C.
Chemical fractions to be tested were prepared by dissolving raw extract X and SPE
fractions B, C in methanol, whereas the more lipophilic SPE fractions D and E were diluted
in methanol–dichloromethane 1:1. The solvent was removed under vacuum, and the
samples were immediately frozen and kept at −20 ◦C until performance of the assay.
3.5. Cytotoxicity Assays
Cytotoxicity experiments were performed on three different cell lines: human cancer
cell lines, A549 (adenocarcinoma human alveolar basal epithelial cells), and A2780 (human
ovarian cancer cell line), together with PNT2 (normal prostate epithelium immortalized
with SV40), all obtained from the American Type Culture Collection (ATCC). A549 cells
were cultured in DMEM F12 (Dulbecco’s modified Eagle’s medium) supplemented with
10% fetal bovine serum (FBS) (Sigma Aldrich), while A2780 and PNT2 cells were in RPMI
(Aurogene) completed with 10% FBS; a total of 100 units mL−1 penicillin and 100 µg·mL−1
streptomycin were added to both media; cells were grown in a 5% CO2 atmosphere at 37 ◦C.
When cells arrived at the maximum confluence of 80%, they were harvested with
Trypsin (Sigma Aldrich), counted, and seeded in 96 (TTP) or 384 (Sarstedt)-well plates. For
96-well plates, we used 2 × 103 cells·well−1 (final volume per well was 100 µL), while for
384-well plates, we used 6 × 102 cells well−1 in 30 µL (final volume per well was 30 µL).
Treatments were added 12–24 h after the seeding.
Chemical extracts and fractions were dissolved in dimethyl sulfoxide (DMSO) and
used for the treatment of cells. The final concentration of the DMSO used was 2% (v/v) for
each treatment. Eighty percent confluent cells were treated in triplicate with fractions of 1,
10 µg mL−1, and in duplicate with those at 100 µg mL−1, for 24 and 48 h in complete cell
medium. Control cells were incubated in complete cell medium with 2% of DMSO.
The antiproliferative effect of samples on cell viability was evaluated using the 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay (Applichem A2231),
according to Gerlier et al. [16]. Briefly, 48 h after treatments, the cell culture media was
discarded and substituted with serum-free media containing 5 µg/mL of the MTT solution.
The plate was incubated for 3 h at 37 ◦C in a 5% CO2 atmosphere. After incubation, the
MTT solution was removed and cells were lysed with isopropanol solution and incubated
at room temperature for 15 min in an orbital shaker. The volumes of the MTT solution and
isopropanol were adapted according to the type of plate used. Absorbance was read at
570 nm using Infinite M1000Pro (TECAN) or MultiSkan FC (Thermo Scientific, Rodano
(MI), Italy) plate readers. The effect of the extracts and fractions at different concentrations
was reported as percent of cell viability, calculated as the ratio between the mean absorbance
of each treatment and the mean absorbance of control (cells treated with only 2% of DMSO).
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3.6. Antibacterial Assays
The antibacterial activity was determined by using the following bacterial strains:
Staphylococcus aureus (ATCC 25923), Escherichia coli (ATCC 25922), Enterococcus faecalis
(ATCC 29212), Pseudomonas aeruginosa (ATCC 27853), and Streptococcus agalactiae (ATCC
12386). Antibacterial test was performed in sterile Muller Hinton broth for E. coli,
P. aeruginosa and S. aureus (Becton Dickinson, Sparks, MD, USA), and in brain heart
infusion broth for E. faecalis and S. agalactiae (Becton Dickinson). The bacterial cultures
were obtained from the stock (−80 ◦C) and were grown on blood agar (acquired from the
University hospital, UiT, Tromsø, Norway) at 37 ◦C for 24 h, and the working bacterial stock
culture was maintained at 4 ◦C. An overnight culture of each strain was prepared and 2 mL
of overnight culture was inoculated into 25 mL of growth media and incubated at 37 ◦C
in the shaker at 180 rpm, until the culture reached turbidity, according to 0.5 McFarland
standard (1.0 × 108 colony forming unit (CFU)/mL). In this study, bacterial cultures were
diluted in 1:100 and then 1:10 in growth media, and the final concentration of bacterial cells
in the wells were adjusted to 0.5–3.0 × 105 (CFU)/mL of S. aureus, E. coli, E. faecalis, and
Streptococcus agalactiae and 3.0–7.0 × 104 CFU/mL of P. aeruginosa.
Chemical fractions were solved in MilliQ H2O with a 20% v/v of DMSO to obtain a
final concentration of 1 µg/µL. The test concentration of 50 µL (=50 µg) was transferred into
a 96-well microtiter plate (NunclonTM Delta Surface, Thermo Fisher Scientific, Waltham,
MA USA). Subsequently, 50 µL of the final concentration of bacterial cells was added and
incubated at 37 ◦C for 20 h. After incubation, the activity was measured as absorbance at
600 nm on a plate reader (1420 Victor3 TM multilabel counter, Perkin Elmer®, JTC MedTech
Hub @ MedTech Park, Singapore) and WorkOut 2.0 software (Dazdaq Ltd., Brighton, UK)
was used for plate reading. A bacterial suspension with MilliQ water was used as growth
control and growth medium, with MilliQ water as media control. In parallel to these tests,
a proper MIC assay was performed as a quality control of the sensitivity of the strains,
using all the mentioned bacterial strains; testing against dilutions of gentamycin (Amresco,
Solon, OH, USA) was used as the reference control for this assay (data not shown). The
inhibition was evaluated by the average of the parallel OD value. The OD value ≤0.05 was
considered as active and ≥0.09 was considered inactive.
3.7. Antidiabetic Assays
To test for an anti-diabetic effect, we applied the enzymatic human recombinant
protein tyrosine phosphatase 1B (PTP-1B, Calbiochem) assay using the fluorescent substrate
6,8—difluoro-4-methylumbelliferyl phosphate (DiFMUP, VWR, Leuven, Belgium). Activity
is proportional to fluorescence. The assay buffer (pH 7.2) consisted of 25 mM Hepes, 50 mM
NaCl, 2 mM Dithriothethreiol, 2.5 mM EDTA, and 0.01 mg/mL Bovine Serum Albumine
(BSA). Assay buffer was used as negative control. The positive control consisted of a
160 µM solution of PTP inhibitor IV (Calbiochem) in assay buffer.
The concentration tested (50 µg/mL of extract or fraction) was obtained by diluting
20 µL of the abovementioned stock solution (1000 µg/mL of extract or fraction, with 20%
vol of DMSO, see Section 3.6) in 80 µL of the assay buffer solution, and using 25 µL of
this working solution in a total reaction volume of 100 µL per well. A total of 50 µL of the
PTP-1B enzyme (31.2 ng/mL) was added to the wells, and this was incubated for 30 min
to allow any potential interaction between the enzyme and the natural products present.
After this first incubation, 25 µL of the 10 µM substrate DiFMUP was added into the wells,
reaching the final reaction volume of 100 µL, and was incubated again at 37 ◦C for 10 min.
Fluorescence was measured using a DTX 880 Multimode Detector (Beckman Coulter,
Brea, California, USA), with an excitation wavelength at (λ) 360 nm and emission at
465 nm. Inhibition was calculated by comparing measurements with controls. The “active”
threshold was set to be below 30% activity. The PTP-1B assay is very sensitive, and
specificity against PTP-1B was checked using the T–Cell-PTP counter screen assay. TC-PTP
is essential for life and very similar to PTP-1B, so if inhibited, the hit will not be followed
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up. The assay is similar to the PTP-1B assay, except that it uses TC-PTP (R&D Systems,
Minneapolis, MN 55413, Toll Free USA, Canada) instead of PTP-1B.
With the positive control, the normal function of the enzyme was established (assigned
to a 100% threshold), and with the negative control, a severe inhibition was measured
(assigned to a 0% threshold). The enzyme activity measurements were expressed as a
percentage related to the controls of the respective plate, and calculated as follows: (average
of test triplicates − negative control average)/(positive control average − negative control
average) × 100.
3.8. Statistical Analisys
Statistical analysis on Phyla data was performed by using non-parametric tests
(Kruskal–Wallis tests) for each cell line (A2780, A549, PNT2) at a dose of 100, 10 and
1 µg/mL. As the Kruskal–Wallis test is significant, i.e., p-value < 0.05, multiple pairwise
comparisons between phylum groups, with corrections for multiple testing (Dunnett’s test),
were computed to identify which phylum groups were statistically different (signif. codes:
0.0001 ‘****’, 0.001 ‘***’, 0.01 ‘**’, 0.05 ‘*’). For our purpose, we show only the difference
between phylum levels and the control group CTRL- (see Figure 2A).
Similarly, Kruskal–Wallis tests followed up by Dunn’s test were applied to identify
which species X, B, C, D, E, including the control group (CTRL-), were different for each
phylum, cell line (A2780, A549, PNT2), and dose (100, 10 and 1 µg/mL).
4. Conclusions
Since the first studies in the early 1960s, MNPs have proved to be a prolific source
of drug candidates, featuring a large chemical diversity and a wide array of biological
activities. The early development of these molecules has had to face several challenges,
including the supply issue and the development of suitable methodologies for chemical
and biological screenings. Thus, despite the progress made in the last decade, there is
a continuous need to explore novel strategies and innovative methods of assessing or
examining the therapeutic potential of these products.
In this work, we tested a library of marine extracts constituted by raw and SPE-
derived fractions against cancer cells, bacterial strains, and cell receptors for potential
anti-diabetic evaluation. Although the SPE samples were composed of heterogeneous
classes of molecules, the pre-fractionation significantly increased the chance of detecting
positive hits. This was particularly evident for the antibacterial and antidiabetic candidates
that were detectable only after fractionation. SPE fractionation also reduced the chemical
variability of small molecules in each fraction, thus simplifying the steps related to the
purification and identification of the active compounds. We focused the analysis on the
major eukaryotic phyla so far explored in marine bioprospecting. An analysis of the
positive hits confirmed sponges as the most prolific source of antitumoral and antibiotic
activities, but it also suggested that other phyla are more suitable in addressing other
therapeutic targets.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/md19110640/s1, Figure S1: Non-parametric test and Post-hoc analysis: for each cell line (A2780,
A549, PNT2) and dose (100, 10, 1 µg/mL), we computed the Kruskal–Wallis test (non-parametric test).
(1) As the p-value was less than the significance level 0.05, we can conclude that there are significant
differences between the Phylum. (2) A multiple pairwise comparison between Phylum is then
performed to calculate pairwise comparisons between Phylum levels, with corrections for multiple
testing (Dunnett’s Test). (3) We show only the comparisons vs. CTRL; Figure S2. Barplot: Log
Fold-Change for significant comparisons (vs. CTRL-); Figure S3: Heatmap showing the percentage of
vitality on the three cell lines (A549, A2780, PTN2) after treatment with the raw extracts (X) and the
corresponding four SPE fractions (B, C, D, E) at 1 and 10 µg/mL; File S1 (cytotoxicity data); File S2
(antibacterial data); File S3 (antidiabetic data).
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